SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India board recommends final dividend

29 Feb 2012 Evaluate

Abbott India has informed that the board of directors of the company at its meeting held on February 28, 2012, has recommended a final dividend of Rs 17.00 per equity share of the face value Rs. 10 on 2, 12, 49,302 equity shares of the company, subject to approval by the shareholders at the annual general meeting of the company to be held on May 14, 2012. The dividend will be dispatched to the shareholders on and from May 21, 2012.

The above information is part of company’s filing submitted to the BSE.

Abbott India Share Price

25574.00 -500.50 (-1.92%)
23-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1867.80
Dr. Reddys Labs. 1301.30
Cipla 1433.10
Zydus Lifesciences 1112.10
Lupin 2356.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: